Could MDMA be useful in the treatment of post‐traumatic stress disorder?
Progress in Neurology and Psychiatry November 1, 2011 DOI: 10.1002/pnp.216 via OpenAlex
Summary
AI-generated from the abstractMDMA has shown promise as an adjunct to psychological therapy for post-traumatic stress disorder (PTSD) in recent studies, but its historical association with the recreational drug ecstasy makes research controversial. Dr Sessa discusses these controversies and describes a UK-based MDMA/PTSD study currently in development.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | MDMA |
| Topics | MDMA PTSD |
| Keywords | Psychology Recreational drug Psychiatry |
| Citations | 24 |
| Key finding | MDMA has shown promise as an adjunct to post-trauma psychological therapy for PTSD, but research remains controversial due to its historical association with ecstasy. |
Abstract
Abstract In recent studies, 3,4‐methylenedioxymethylamphetamine (MDMA) has shown promise in the treatment of post‐traumatic stress disorder (PTSD) as an adjunct to post‐trauma psychological therapy. However, because of historical associations with its use as the recreational drug ecstasy, MDMA research remains a controversial subject. Dr Sessa discusses these controversies and describes a UK‐based MDMA/PTSD currently in development. Copyright © 2011 John Wiley & Sons, Ltd.